In previous studies, the human liver disease accompanying KIF12 mutations have been simply described as ‘cholestasis’ (Maddirevula et al, 2019; Stalke et al, 2021; Unlusoy Aksu et al, 2019). This evidence concerns the gene KIF12 and cholestasis.